Group 1: Public Fund Industry - In 2026, public fund companies showed strong enthusiasm for self-purchase, with 24 companies implementing self-purchases totaling 406 million yuan, over 80% of which was directed towards equity funds [1] - Among the self-purchases, stock funds received 100 million yuan and mixed funds received 248 million yuan, while bond funds received 30 million yuan [1] - Ruifeng Fund led the self-purchase with 100 million yuan, while several other companies, including GF Fund and China Merchants Fund, each self-purchased 20 million yuan [1] Group 2: Payment Industry - The number of third-party payment licenses is continuously decreasing, with the first company, Henan Jubao Payment, exiting the market in 2026 [2] - The decline in payment institutions is attributed to structural reshuffling and regulatory upgrades within the industry [2] - Traditional payment businesses are under pressure, with many companies reporting declines in net profit after excluding non-recurring gains, prompting a need for transformation towards cross-border payments and AI integration [2] Group 3: Refrigerant Industry - The refrigerant market remains strong despite being in the traditional off-season, with prices for R32 and R134a increasing by approximately 45% and 32% year-on-year, respectively [2] - The industry is expected to see long-term price increases due to strict global supply constraints and growing downstream demand [2] - Major companies are primarily executing long-term contracts, but market prices are expected to exceed contract prices, indicating a robust pricing environment [2] Group 4: Smartphone Market in India - The Indian smartphone market saw a 1% year-on-year increase in shipments in 2025, with sales revenue growing by 8% due to a shift towards high-end devices [3] - However, a single-digit decline in shipments is anticipated for 2026, particularly in the segment priced below 15,000 Indian Rupees, due to rising costs of components [3] - The average selling price (ASP) is expected to increase by 5%-7% as major OEMs focus on high-end strategies [3] Group 5: Nanobody Research - Research indicates that nanobodies extracted from llamas show potential in treating various diseases, including depression, prompting significant investment from pharmaceutical companies [4] - The development of next-generation nanobody drugs is seen as a breakthrough in precision medicine [4] Group 6: Cancer Burden Quantification - The IARC and WHO quantified the global burden of preventable cancers, revealing that nearly 40% of new cancer cases in 2022 were linked to modifiable risk factors [4] - The findings emphasize the importance of reducing smoking, infections, and alcohol consumption in cancer prevention efforts [4] Group 7: PayPal's Financial Performance - PayPal's fourth-quarter earnings and revenue fell short of expectations, leading to a significant drop in stock price and a change in CEO [5] - The company reported earnings of $1.23 per share and total revenue of $8.68 billion, both below analyst forecasts [5] Group 8: Tianqi Lithium Industry - Tianqi Lithium suspended trading in Hong Kong as it plans to dispose of part of its stake in SQM, with a maximum of 3.566 million A shares to be sold [6] - The company has already disposed of 748,500 B shares, and as of the announcement date, it holds 62.556 million A shares, representing 21.90% of SQM's total shares [6] Group 9: Corporate Governance Issues - Gaoxin Retail announced difficulties in contacting its CEO, but the board believes this will not significantly impact operations [7] - The Shanghai Stock Exchange issued a regulatory warning to Pengxin Resources for failing to appoint a board secretary, which has been vacant since January 2022 [8]

美国迈阿密大学与法国图尔大学科学家在近日 出版的《自然·通讯》杂志发表论文称，从羊驼体内提取 的纳米抗体，在治疗压力诱导的抑郁小鼠模型中，展现出快速起效、持久稳定的抗抑郁效果。研究显 示，这些"小而强"的纳米抗体展现出对抗多种疾病的潜力。各大药企正投入数十亿美元，致力于开发新 一代纳米抗体药物，以治疗癌症、神经痛和慢性皮肤病等疑难杂症，为精准医疗打开新大门。 ...